VEGFA and metastatic colorectal cancer: Serum bFGF levels have been shown to be increased following first-line treatment of patients with metastatic colorectal cancer treated with combination chemotherapy and monoclonal anti-VEGF antibody therapy (Kopetz et al, 2009).